dc.contributor.author | Ozisik, Lale | |
dc.contributor.author | Tanriover, Mine Durusu | |
dc.contributor.author | Basaran, Nursel Calik | |
dc.contributor.author | Oz, S. Gul | |
dc.contributor.author | Unal, Serhat | |
dc.date.accessioned | 2019-12-10T11:14:58Z | |
dc.date.available | 2019-12-10T11:14:58Z | |
dc.date.issued | 2015 | |
dc.identifier.issn | 2164-5515 | |
dc.identifier.uri | https://doi.org/10.1080/21645515.2015.1070999 | |
dc.identifier.uri | http://hdl.handle.net/11655/15187 | |
dc.description.abstract | Many infectious diseases in adults can be prevented by a life-long vaccination strategy'. Hepatitis B disease burden was shown to be higher in diabetic patients. American Advisory Committee on Immunization Practices recommends to vaccinate diabetic patients against hepatitis B since 2011. In this study, we aimed to determine hepatitis B virus serology status to determine the rates of diabetic patients who have indications for hepatitis B vaccination. The electronic database of the hospital was searched to identify adult patients aged above 18years and with hemoglobin A(1)C levels of 6.5% or above, who have been seen at General Medicine Outpatient Clinics of a university hospital during a 3-year period. A total of 5187 patients were included in the study. After exclusion of patients with an incomplete serological panel, 1358 patients were included for further analyses. Twenty-nine percent of the patients had indication for hepatitis B vaccination, whereas only 8% were vaccinated. This study showed that nearly one third of patients who had hepatitis B serological data had an indication for hepatitis B vaccination and this is a clear reflection of the need to keep a lifelong vaccination log and inquire vaccination data. | |
dc.language.iso | en | |
dc.publisher | Taylor & Francis Inc | |
dc.relation.isversionof | 10.1080/21645515.2015.1070999 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Biotechnology & Applied Microbiology | |
dc.subject | Immunology | |
dc.title | Missed Opportunities For Hepatitis B Vaccination Among Diabetic Patients | |
dc.type | info:eu-repo/semantics/article | |
dc.relation.journal | Human Vaccines & Immunotherapeutics | |
dc.contributor.department | İç Hastalıkları | |
dc.identifier.volume | 11 | |
dc.identifier.issue | 12 | |
dc.identifier.startpage | 2806 | |
dc.identifier.endpage | 2810 | |
dc.description.index | WoS | |